We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.06B
Cap. Flow
-$252M
Cap. Flow %
-1.29%
Top 10 Hldgs %
27.73%
Holding
2,867
New
60
Increased
922
Reduced
1,499
Closed
102

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.2M
2
NVDA icon
NVIDIA
NVDA
+$28.8M
3
SNV
Synovus
SNV
+$21M
4
AUB icon
Atlantic Union Bankshares
AUB
+$20.5M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 12.71%
3 Industrials 10.47%
4 Healthcare 10.16%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYFT icon
2451
Lyft
LYFT
$5.87B
$121K ﹤0.01%
9,079
-181
-2% -$2.8K
BETR icon
2452
Better Home & Finance Holding
BETR
$423M
$120K ﹤0.01%
3,380
ARDT
2453
Ardent Health
ARDT
$1.64B
$120K ﹤0.01%
14,030
LRMR icon
2454
Larimar Therapeutics
LRMR
$398M
$120K ﹤0.01%
26,668
+13,071
+96% +$52.2K
CDZI icon
2455
Cadiz
CDZI
$259M
$120K ﹤0.01%
24,415
+2,697
+12% +$14.7K
ACCO icon
2456
Acco Brands
ACCO
$401M
$120K ﹤0.01%
39,944
+9,398
+31% +$35.4K
FDBC icon
2457
Fidelity D&D Bancorp
FDBC
$308M
$120K ﹤0.01%
2,766
NGNE icon
2458
Neurogene
NGNE
$663M
$120K ﹤0.01%
5,932
DDD icon
2459
3D Systems Corp
DDD
$412M
$119K ﹤0.01%
63,429
+27,010
+74% +$60K
INV
2460
Innventure Inc
INV
$249M
$119K ﹤0.01%
+30,421
New +$107K
RARE icon
2461
Ultragenyx Pharmaceutical
RARE
$2.56B
$119K ﹤0.01%
5,672
-282
-5% -$6.35K
MTCH icon
2462
Match Group
MTCH
$9.16B
$118K ﹤0.01%
3,857
-52,794
-93% -$1.65M
PKOH icon
2463
Park-Ohio Holdings
PKOH
$564M
$118K ﹤0.01%
4,927
RNA
2464
Atrium Therapeutics
RNA
$197M
$118K ﹤0.01%
+8,845
New +$124K
TNXP icon
2465
Tonix Pharmaceuticals
TNXP
$158M
$118K ﹤0.01%
8,590
+3,975
+86% +$61.2K
CE icon
2466
Celanese
CE
$4.77B
$118K ﹤0.01%
1,792
+3
+0.2% +$157
HPP
2467
Hudson Pacific Properties
HPP
$765M
$118K ﹤0.01%
19,925
-8,045
-29% -$61.8K
STRS icon
2468
Stratus Properties
STRS
$156M
$117K ﹤0.01%
3,840
LNKB
2469
DELISTED
LINKBANCORP
LNKB
$117K ﹤0.01%
14,038
WEAV icon
2470
Weave Communications
WEAV
$548M
$116K ﹤0.01%
25,166
-9,640
-28% -$56.1K
USAU icon
2471
US Gold Corp
USAU
$209M
$116K ﹤0.01%
7,651
MITT
2472
TPG Mortgage Investment Trust
MITT
$230M
$116K ﹤0.01%
15,896
+5,003
+46% +$41.4K
RR icon
2473
Richtech Robotics
RR
$322M
$116K ﹤0.01%
55,567
-31,713
-36% -$97.5K
SRPT icon
2474
Sarepta Therapeutics
SRPT
$1.63B
$116K ﹤0.01%
5,335
+97
+2% +$1.88K
CERS icon
2475
Cerus
CERS
$585M
$116K ﹤0.01%
63,517
-28,101
-31% -$61.2K

Similar funds

MetLife Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, MetLife Investment Management held 2,867 positions worth $19.6B, down 5.1% from $20.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

MetLife Investment Management's Q1 2026 filing shows 60 new, 922 increased, 1,499 reduced and 102 closed positions. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M. The largest sale was Apple, an estimated $32.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

  • MetLife Investment Management's largest Q1 2026 buy was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $62.3M increase.
  • MetLife Investment Management's biggest Q1 2026 reduction was Apple, cutting an estimated $32.2M.
  • MetLife Investment Management fully exited Synovus in Q1 2026, selling an estimated $21M.
  • MetLife Investment Management's ten largest holdings make up 28% of its $19.6B portfolio in Q1 2026.
  • MetLife Investment Management opened 60 new positions and closed 102 in Q1 2026.
  • MetLife Investment Management's portfolio value fell 5.1% quarter-over-quarter to $19.6B.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.